PharmaTher Announces Grant of Stock Options
Portfolio Pulse from
PharmaTher Holdings Ltd. has granted 800,000 stock options to two of its directors at an exercise price of $0.22 per share. These options vest immediately and have a five-year term. The Chairman and CEO did not receive any options.
January 03, 2025 | 10:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
PharmaTher has granted 800,000 stock options to two directors, which may influence stock price due to potential dilution and insider confidence.
The grant of stock options can lead to potential dilution of shares, which might affect the stock price. However, the immediate vesting and exclusion of the CEO from the grant could indicate confidence in the company's future, balancing the impact.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80